Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

19 Nov 2007 11:15

Skyepharma PLC19 November 2007 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: SkyePharma plc 2. Reason for the notification (please tick the appropriate box or boxes) An acquisition or disposal of voting rights x An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights Other (please specify):___________________________________________ 3. Full name of person(s) subject to the notification obligation: OrbiMed Advisors LLC 4. Full name of shareholder(s) (if different from 3.): Caduceus Capital Master Fund Limited Caduceus Capital II, L.P. UBS Eucalyptus Fund, L.L.C PW Eucalyptus Fund, Ltd. Summer street Life Sceinces Hedge Fund Investors LLC 5. Date of the transaction (and date on which the threshold is crossed or reached if different): November 15,2007 6. Date on which issuer notified: November 16, 2007 7. Threshold(s) that is/are crossed or reached: 3% 8. Notified details: A: Voting rights attached to sharesClass/type of Situation previous to the Resulting situation after the triggering transaction(i)shares Triggering transaction Number of Number of Number of Number of voting rights % of voting rights if possible using Shares Voting sharesthe ISIN CODE Rights Direct Direct Indirect Direct Indirect GB0008123571 24,230,000 24,230,000 30,230,000 30,230,000 3.71% B: Financial InstrumentsResulting situation after the triggering transactionType of financial Expiration date Exercise/ Conversion Number of voting rights % of votinginstrument Period/ Date that may be acquired if rights the instrument is exercised/ converted. Total (A+B)Number of voting rights % of voting rights 30,230,000 3.71% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: Not Applicable Proxy Voting: 10. Name of the proxy holder: Not Applicable 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional information: Not Applicable 14. Contact name: Eric Bittelman 15. Contact telephone number: 001-212-739-6400 Annex Notification Of Major Interests In SharesA: Identity of the person or legal entity subject to the notification obligationFull name (including legal form for legal entities)Contact address (registered office for legal entities)Phone numberOther useful information (at least legal representative forlegal persons) B: Identity of the notifier, if applicableFull nameContact addressPhone numberOther useful information (e.g. functional relationship withthe person or legal entity subject to the notificationobligation) C: Additional information -------------------------- This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Jun 20163:20 pmRNSForm 8.3 - Skypepharma PLC
1st Jun 201612:29 pmRNSForm 8.3 - Skyepharma PLC
1st Jun 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
1st Jun 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
1st Jun 201610:51 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
1st Jun 201610:09 amRNSForm 8.3 - Vectura Group plc
1st Jun 20169:30 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
31st May 20163:30 pmRNSForm 8.3 - [VEC/SKP]
31st May 20163:30 pmRNSForm 8.3 - [SKP/VEC]
31st May 20163:20 pmRNSForm 8.3 - Skyepharma PLC
31st May 20161:24 pmRNSForm 8.3 - Vectura Group Plc
31st May 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
31st May 201610:36 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
31st May 20169:37 amRNSForm 8.3 - Vectura Group plc
31st May 20168:55 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
31st May 20167:00 amRNSForm 8.3 - Skyepharma PLC
27th May 20163:30 pmRNSForm 8.3 - [VEC/SKP]
27th May 20163:30 pmRNSForm 8.3 - [SKP/VEC]
27th May 20163:20 pmRNSForm 8.3 - Skyepharma PLC
27th May 20161:58 pmRNSForm 8.3 - [Skyepharma plc]
27th May 20161:55 pmRNSForm 8.3 - Vectura Group Plc
27th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
27th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
27th May 201610:24 amRNSForm 8.3 - Vectura Group plc
27th May 201610:16 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
27th May 20169:49 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
26th May 20163:30 pmRNSForm 8.3 - [VEC/SKP]
26th May 20163:30 pmRNSForm 8.3 - [SKP/VEC]
26th May 20163:20 pmRNSForm 8.3 - Skyepharma PLC
26th May 20162:46 pmRNSForm 8.3 - Skyepharma
26th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
26th May 201610:13 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
26th May 20169:04 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
26th May 20168:52 amRNSForm 8.3 - Vectura Group plc
25th May 20163:30 pmRNSForm 8.3 - [VEC/SKP]
25th May 20163:30 pmRNSForm 8.3 - [SKP/VEC]
25th May 20163:23 pmRNSForm 8.3 - Skyepharma Plc
25th May 20163:20 pmRNSForm 8.3 - Skyepharma PLC
25th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
25th May 201610:13 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
25th May 20169:28 amRNSForm 8.3 - Vectura Group plc
25th May 20169:07 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
24th May 20163:30 pmRNSForm 8.3 - [VEC/SKP]
24th May 20163:30 pmRNSForm 8.3 - [SKP/VEC]
24th May 20163:20 pmRNSForm 8.3 - Skyepharma PLC
24th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
24th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
24th May 201610:55 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
24th May 20169:37 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
24th May 20169:33 amRNSForm 8.3 - Skyepharma Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.